Status:
COMPLETED
Optimizing Veteran-Centered Prostate Cancer Survivorship Care
Lead Sponsor:
VA Office of Research and Development
Conditions:
Prostate Cancer
Eligibility:
MALE
40-80 years
Phase:
NA
Brief Summary
This study will provide much needed information about how to optimize the quality of care and quality of life of Veterans who are survivors of prostate cancer.
Detailed Description
Although there are nearly 150,000 prostate cancer survivors in the VA, there has been little research to understand and improve survivorship care for this large population of Veterans. A substantial p...
Eligibility Criteria
Inclusion
- Veteran patient at one of the four study sites (Ann Arbor VA, Cleveland VA, Pittsburgh VA, St. Louis VA)
- History of treatment for prostate cancer treated by surgery, radiation or androgen deprivation therapy between 1-10 years prior to identification
Exclusion
- No phone number on file
- Not able to converse on the telephone in English
- Treated for metastatic disease or non-prostate cancer
- Dementia or other significant mental impairment
Key Trial Info
Start Date :
April 17 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 7 2018
Estimated Enrollment :
556 Patients enrolled
Trial Details
Trial ID
NCT01900561
Start Date
April 17 2015
End Date
February 7 2018
Last Update
May 7 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan, United States, 48105
2
St. Louis VA Medical Center John Cochran Division, St. Louis, MO
St Louis, Missouri, United States, 63106
3
Louis Stokes VA Medical Center, Cleveland, OH
Cleveland, Ohio, United States, 44106
4
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Pittsburgh, Pennsylvania, United States, 15240